17 Capital Partners’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$432K Buy
34,844
+2,472
+8% +$43.2K 0.59% 61
2022
Q2
$635K Hold
32,372
0.8% 51
2022
Q1
$845K Buy
32,372
+52
+0.2% +$1.39K 0.88% 47
2021
Q4
$917K Sell
32,320
-5,274
-14% -$164K 0.84% 46
2021
Q3
$1.2M Hold
37,594
1.13% 35
2021
Q2
$1.3M Buy
+37,594
New +$1.24M 1.21% 26

Other funds holding ELAN

17 Capital Partners's ELAN Position: Q3 2022 in Review

17 Capital Partners increased its Elanco Animal Health (ELAN) stake by 7.6% in Q3 2022, buying an estimated $43.2K and bringing the position to 34,844 shares worth $432K. The position accounts for 0.59% of the portfolio, ranked #61.

17 Capital Partners first reported a position in ELAN in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.3M in Q2 2021. 419 funds tracked by Wall St. Rank hold ELAN as of Q3 2022.

  • 17 Capital Partners held 34,844 shares of Elanco Animal Health worth $432K as of Q3 2022.
  • 17 Capital Partners bought 2,472 Elanco Animal Health shares in Q3 2022, an estimated $43.2K.
  • Elanco Animal Health made up 0.59% of 17 Capital Partners's portfolio in Q3 2022, its #61 holding.
  • 17 Capital Partners first reported a position in Elanco Animal Health in Q2 2021 and has held it in 6 quarters since.
  • 17 Capital Partners's Elanco Animal Health position peaked at $1.3M in Q2 2021.
  • 419 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2022.

Based on 17 Capital Partners's 13F filing for Q3 2022, filed 21 Nov 2022.